Clinical Trials Logo

Citation(s)

On-admission Multifactorial Evaluation of Inflammation as Prognostic Marker of Death in Patients Diagnosed With Coronavirus Infectious Disease (COVID-19) Syndrome

Details for clinical trial NCT04371471